The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period

Completed · Phase 2 · Has a placebo group

Conditions studied: Blepharitis

In brief

The objective of this study is to compare the safety and efficacy of azithromycin ophthalmic solution, 1% versus placebo over a two-week treatment period.

Key facts

Study ID
NCT00892970
Run by
Merck Sharp & Dohme LLC
People needed
313
Starts
2009-04-01
Expected to finish
2010-01-01
Last updated by the study team
2011-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.